期刊文献+

金雀异黄酮在体内对CYP3A活性的影响 被引量:4

Effects of genistein on cytochrome P450 3A activity in healthy volunteers
下载PDF
导出
摘要 目的:阐明金雀异黄酮在体内对细胞色素氧化酶P-4503A(CYP3A)活性的影响。方法:本试验采用双周期交叉临床试验。临床试验按照两阶段交叉方案进行。第一阶段随机分成的2组受试者随机给予金雀异黄酮片或安慰剂处理14 d,第15天给所有受试者米哒唑仑探针药,经过14 d洗脱期后交叉重复试验,分别以0~36 h血浆中米哒唑仑的血浆曲线下面积、半衰期作为CYP3A的活性指标。HPLC测定其活性。服药后0~36 h血中咪达唑仑以及1'-羟基咪达唑仑用HPLC-MS/MS方法测定。结果:经金雀异黄酮处理后,咪达唑仑AUC0-36 h明显降低[(144±55)ng.mL-1.hvs(126±40)ng.mL-1.h,P〈0.05],AUC0-∞显著降低[(209±57)vs(181±43)ng.mL-1.h,P〈0.05],Cmax显著降低[(49±20)vs(36±14),P〈0.05]。结论:金雀异黄酮对体内CYP3A酶活性具有显著的诱导作用,应当关注经CYP3A代谢的药物与金雀异黄酮合用时可能发生的潜在的药物相互作用。 AIM:To examine the potential effects of genistein on CYP3A activity. METHODS: The experiment was conducted in an open,randomized,2-period crossover study.The probe drug midazolam was used as an indicator of CYP3A function.Every volunteer was administered orally,once a day for 14 days,genistein 1000 mg or placebo(control).On 15th day,a 7.5 mg midazolam was administrated orally.The plasma concentration of midazolam,1-OH midazolam was determined over 36 h.RESULTS:Coadministration of genistein obviously decreased the area under the curve AUC0-36 of midazolam [(144±55) ng·mL-1·h vs(126±40) ng·mL-1·h,P0.05],and significantly decreased AUC0-∝ of midazolam[(209±57) vs(181±43) ng·mL-1·h,P0.05],and also decreased Cmax of midazolam[(49±20) vs(36±14),P0.05].CONCLUSION: Genistein,a principal isoflavone in soybean,in regular doses may induce CYP3A activity in vivo,and it should be aware of potential drug-food interactions.
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第6期643-646,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金(30528026 30300428 30672497 30500623) 纽约中华医学会基金(01-755)
关键词 金雀异黄酮 CYP3A酶活性 药代动力学 Genistein CYP3A activity Pharmacokinetics
  • 相关文献

参考文献11

  • 1Mackenzie PI, Owens IS, Burchell B, et al. The UDP glycosyltransferase gene superfamily: recom- mended nomenclature update based on evolutionary divergence[J]. Pharmacogenetics, 1997,7 (4) : 255 --269.
  • 2Mackenzie PI, Bock KW, Burchell B, et al. No menclature update for the mammalian UDP glyeo syltransferase (UGT) gene superfamily[J]. Phar maeogenet Genomics, 2905,15 (10) : 677 - 685.
  • 3Lehmann JM, Mckee DD, Watson MA, et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interaetions[J]. J Clin Invest,1998, 102(5) :1016-1023.
  • 4Xu C, I.i CY, Kong AN,et al. Induction of phase I, II and III drug metabolism/transport by xenobi- otics[J]. Arch Pharm Res,2005,28(3):249--268.
  • 5Sparreboom A, Danesi R, Ando Y, et al. Pharmacogenomics of ABC transporters and its role in cancer chemotherapy [J]. Drug Resist Updat, 2003, 6(2):71-84.
  • 6Thummel KE, O'Shea D, Paine MF, et al. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism[J]. Clin Pharmacol Ther, 1996,59 (5) 491--502.
  • 7TanabeM, Ieiri I, Nagata N, et al. Expression of P-glycoprotein in human placenta: relation to ge- netic polymorphism of the muhidrug resistance (MDR 1) gene[J]. J Pharmacol Exp Ther, 2001, 297(3): 1137-1143.
  • 8Banerjee S, I.i Y, Wang Z, et al. MuIti-targeted therapy of cancer by genistein[J]. Cancer Lett, 2008,269(2) :228-242.
  • 9Ameyaw MM, Regateiro F, Li T, et al. MDR1 pharmacogenetics., frequency of the C3435T muta- tion in exon 26 is significantly influenced by ethnici- ty[J]. Pharmacogenetics, 2001, 11(3): 217-221.
  • 10Chen C, Zhou J, Ji C. Quercetin: A potential drug to reverse multidrug resistance[J]. Life Sciences, 2010,87(11/12) :333--338.

二级参考文献10

  • 1Landes N, Pfluger P, Kluth D,et al. Vitamin E activates gene expression via the pregnane X receptor [J]. BiochemPharmaeol, 2003,65(2):269--273.
  • 2Mustacich DJ, Leonard SW, Devereaux MW, et al. α- Toeopherol regulation of cytochrome P450s and ABC transporters in rats[J]. Free Radical Biol Med, 2006,41(7):1069 -1078.
  • 3Leonard SW, Paterson E, Atkinson JK, et al. Studies in humans using deuterium labeled alpha- and gamma-tocopherols demonstrate faster plasma gamma-tocopherol disappearance and greater gamma-metabolite production[J]. Free Radic Biol Med, 2005,38(7) :857--866.
  • 4Cheung MC, Zhao XQ, Chair A, et al. Antioxidant supplements block the response of HDL to simvastatin niacin therapy in patients with coronary artery disease and low HDL [J]. Arterioseler Thromb Vasc Biol, 2001,21 (8):1320--1326.
  • 5Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease[J]. N Engl J Med, 2001,345 (22) : 1583--1592.
  • 6Prueks T,Gorham LM,Liu L,et al. In vitro metabolism of simavastatin in humans identification of metabolizing enzymes and effect of the drug on hepatic P450s [J]. Drug MetabDispos,1997,25 (10) :1191 --1199.
  • 7Bogman K, Peyer AK, Torok M, et al. HMG-CoA reductase inhibitors and P glycoprotein modulation [J]. Br J Pharmacol, 2001, 132(6): 1183--1192.
  • 8Sakaecla T, Takara K, Kakumoto M, et al. Simvastatin and Iovastatin, but not pravastatin, interact with MDR1[J]. J Pharm Pharmacol, 2002, 54(3): 419--423.
  • 9Chen C, Mireles RJ, Campbell SD, et al. Differential interaction of 3-hydroxy-3-methylglutaryl-eoa reductase inhibitors with ABCB1, ABCC2, and OATP1B1[J]. Drug Metab Dispos, 2005, 33(4) : 537--546.
  • 10段娟,张松波,张赛丹.天然维生素E对辛伐他汀体内代谢的影响[J].中国临床药理学与治疗学,2008,13(3):323-327. 被引量:2

共引文献3

同被引文献44

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部